(SOURCE: RUSH UNIVERSITY MEDICAL CENTER) – A new therapy to treat spinal cord injuries in people who have lost all motor and sensory function below the injury site shows additional motor function improvement at 6-months and 9-months following treatment with 10 million AST-OPC1. The positive efficacy results from an ongoing research study were announced on Jan. 24 […]
(WOLTERS KLUWER HEALTH) According to a recent press release from Wolters Kluwer Health, a new high-frequency spinal cord stimulation (SCS) technique for patients with severe, chronic back and leg pain provides superior clinical outcomes, compared to conventional low-frequency SCS, reports a clinical trial in the November issue of Neurosurgery, official journal of the Congress of […]
(Live Science) According to an article recently published in Live Science, a medical device that was implanted into a man’s brain has restored his feelings of touch, according to a new study. This is the first time such a device has been used to restore a sense of touch in a person with a spinal […]
(PR Newswire) Keck Medical Center of USC recently announced that a team of doctors became the first in California to inject an experimental treatment made from stem cells, AST-OPC1, into the damaged cervical spine of a recently paralyzed 21-year-old man as part of a multi-center clinical trial.
(San Jose Mercury News) According to a recent article published in the Mercury News, researchers have successfully transplanted healthy human cells into mice with spinal cord injuries, bringing the world one step closer to easing the chronic pain and incontinence suffered by people with paralysis.